Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

Market Cap	4.19B +50.6%
Revenue (ttm)	412.52M -5.9%
Net Income	85.70M -18.5%
EPS	0.88 -18.2%
Shares Out	97.81M
PE Ratio	48.84
Forward PE	n/a
Dividend	0.80 (1.81%)
Ex-Dividend Date	May 26, 2026

Volume	466,850
Open	43.56
Previous Close	44.18
Day's Range	42.03 - 44.37
52-Week Range	26.38 - 61.22
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHA:688273

Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vaginal electrodes, rectal electrodes, vaginal probes, etc. The company also provides pelvic floor muscle rehabilitation, biological feedback and stimulation...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 550
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688273

Financial Performance

In 2025, SHA:688273's revenue was 431.59 million, an increase of 1.66% compared to the previous year's 424.55 million. Earnings were 102.63 million, an increase of 1.03%.